ANI PHARMACEUTICALS INC (ANIP) Institutional Ownership Changes & 13F Activity
ANI PHARMACEUTICALS INC (ANIP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Invesco Ltd., Ameriprise Financial Inc, Rubric Capital Management Lp, Sio Capital Management, Llc, and Freestone Grove Partners Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +1,111 | +11.6% | 10,688 | $884.75K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -19,000 | -16.5% | 96,082 | $7.95M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +11,754 | +95.2% | 24,106 | $2.00M | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -595 | -2.4% | 23,962 | $1.98M | Q2 2026 | Aug 24, 2026 |
| Jefferies Financial Group Inc. | Sell | -8,739 | -72.8% | 3,261 | $269.95K | Q2 2026 | Aug 17, 2026 |
| Capstone Investment Advisors, Llc | Buy | +1,485 | +15.4% | 11,150 | $923.00K | Q2 2026 | Aug 17, 2026 |
| Invesco Ltd. | Buy | +309,233 | — | 309,233 | $25.60M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +287,382 | — | 287,382 | $23.79M | Q2 2026 | Aug 14, 2026 |
| Rubric Capital Management Lp | Buy | +258,131 | — | 258,131 | $21.37M | Q2 2026 | Aug 14, 2026 |
| Sio Capital Management, Llc | Sell | -168,238 | -63.4% | 97,305 | $8.05M | Q2 2026 | Aug 14, 2026 |
| Freestone Grove Partners Lp | Sell | -152,898 | -60.1% | 101,332 | $8.39M | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Sell | -144,412 | -77.8% | 41,217 | $3.41M | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Sell | -128,198 | -61.4% | 80,496 | $6.66M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +125,000 | +85.0% | 272,085 | $22.52M | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Sell | -95,890 | -70.6% | 40,000 | $3.31M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -84,806 | -14.3% | 507,207 | $41.99M | Q2 2026 | Aug 14, 2026 |
| Parkman Healthcare Partners Llc | Sell | -77,668 | -27.7% | 202,907 | $16.80M | Q2 2026 | Aug 14, 2026 |
| Csm Advisors, Llc | Buy | +72,546 | +256.2% | 100,860 | $8.35M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +52,260 | +77.5% | 119,707 | $9.91M | Q2 2026 | Aug 14, 2026 |
| Raymond James Financial Inc | Buy | +50,650 | +62.8% | 131,270 | $10.87M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +46,176 | +274.3% | 63,008 | $5.21M | Q2 2026 | Aug 14, 2026 |
| Oberweis Asset Management Inc/ | Buy | +43,920 | +19.8% | 265,306 | $21.96M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Sell | -38,701 | -18.1% | 174,732 | $14.46M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -37,519 | -17.1% | 182,236 | $15.09M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -37,088 | -58.4% | 26,450 | $2.19M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +33,625 | +82.5% | 74,368 | $6.16M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +32,838 | — | 32,838 | $2.72M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -32,577 | -33.7% | 64,232 | $5.32M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +32,534 | +21.6% | 183,066 | $15.15M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -31,984 | -59.1% | 22,130 | $1.83M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ANIP activity
Which institutional owners are buying ANIP?
Institutional owners buying ANIP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ANIP activity?
"Buy" means an investor increased their reported position in ANIP compared to the prior reporting period. This reflects growing exposure to ANI PHARMACEUTICALS INC (ANIP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ANIP increasing?
Institutional interest in ANIP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ANIP Institutional Insights
- ANIP Overview
- ANIP 13F Institutional Holders
- ANIP Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ANIP Insider Trading & SEC Form 4 Activity
- ANIP Articles
- Top Institutional Investor Stock Rankings